Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL479164 | 0.95 | — | — | |
| Bromide SCHEMBL28628607 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL3629382 | 0.78 | — | — | |
| Acetone SCHEMBL28230335 | 0.78 | LMNA (0.40) | — | |
| Hydrochloric Acid SCHEMBL28244693 | 0.76 | — | — | |
| Trimethylammonium SCHEMBL11572782 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL5846270 | 0.74 | — | — | |
| SCHEMBL28286692 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL11280437 | 0.73 | ALDH1A1 (0.42) | — | |
| Hydrochloric Acid SCHEMBL7373341 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041958-A | Graphene modified nylon special-shaped fiber and preparation process thereof | 江苏江山红化纤有限责任公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119898088-A | Dynamically-adjusted coated glass, and preparation method and detection method thereof | 江苏城乡建设职业学院 | 2025-04-29 | — | — | CN | claimed |
| CN-119735773-A | Antibacterial urea resin and preparation method thereof | 山东高兴新材料股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119565892-A | Electronic product shell based on PU coating and preparation method thereof | 广东纵胜新材料股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-116177508-B | Two-dimensional aluminum phosphate material and preparation method and application thereof | 仲恺农业工程学院 | 2025-03-04 | — | — | CN | claimed |
| CN-118322676-B | Self-powered dimming energy-saving hollow glass and preparation method thereof | 江苏城乡建设职业学院 | 2025-02-28 | — | — | CN | claimed |
| CN-116693747-B | Viscosity-increasing type temperature-resistant salt-tolerant polymer filtrate reducer and preparation method and application thereof | 长江大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119352291-A | Modified polyester fiber and antibacterial antistatic fabric | 江苏国望高科纤维有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118600734-B | Modified polyester fiber and preparation method and application thereof | 江苏国望高科纤维有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118878538-A | Novel preparation method of green lumepiquat chloride | 江苏宝东医药科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-20040208833-A1 | Novel fluticasone formulations | ELAN PHARMA INTERNATIONAL LTD. | 2004-10-21 | — | — | US | claimed |
| WO-2004078162-A1 | NANOPARTICULATE TOPIRAMATE FORMULATIONS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2004-09-16 | — | — | WO | claimed |
| US-20040164194-A1 | System and method for milling materials | ELAN PHARMA INTERNATIONAL LIMITED | 2004-08-26 | — | — | US | claimed |
| WO-2004069225-A1 | NOVEL FLUTICASONE FORMULATIONS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2004-08-19 | — | — | WO | claimed |
| WO-2004050059-A1 | LOW VISCOSITY LIQUID DOSAGE FORMS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2004-06-17 | — | — | WO | claimed |
| US-20040105889-A1 | Low viscosity liquid dosage forms | ELAN PHARMA INTERNATIONAL LIMITED | 2004-06-03 | — | — | US | claimed |
| US-20030185869-A1 | Having lysozyme adsorbed onto or associated with the surface of an active agent | ELAN PHARMA INTERNATIONAL LTD. | 2003-10-02 | — | — | US | claimed |
| WO-2003066021-A2 | DRUG NANOPARTICLES WITH LYSOZYME SURFACE STABILISER | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2003-08-14 | — | — | WO | claimed |
| US-5382663-A | Catalytic alkylation with dimethyl-2-chloroethylamine hydrochloride; acetylation; salt formation | LUSOCHIMICA S.P.A. (IT) | 1995-01-17 | — | — | US | claimed |
| EP-0537608-A2 | Process for the technical preparation of 2,2-diphenyl-2-(2-ethyl-butoxy)acetic acid, 2-dimethyl-amino-ethyl ester, hydrochloride | APOGEPHA ARZNEIMITTEL GmbH (DE) | 1993-04-21 | — | — | EP | claimed |